Birgitta Rembeck

673 total citations
8 papers, 499 citations indexed

About

Birgitta Rembeck is a scholar working on Neurology, Pathology and Forensic Medicine and Biological Psychiatry. According to data from OpenAlex, Birgitta Rembeck has authored 8 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Neurology, 2 papers in Pathology and Forensic Medicine and 2 papers in Biological Psychiatry. Recurrent topics in Birgitta Rembeck's work include Neurofibromatosis and Schwannoma Cases (5 papers), Sarcoma Diagnosis and Treatment (2 papers) and Tryptophan and brain disorders (2 papers). Birgitta Rembeck is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (5 papers), Sarcoma Diagnosis and Treatment (2 papers) and Tryptophan and brain disorders (2 papers). Birgitta Rembeck collaborates with scholars based in Sweden, France and Poland. Birgitta Rembeck's co-authors include Lennart Angervall, Madeleine E.T. Zöller, Hans Olof Åkesson, Lars Bäckman, Anders Odén, Daniel Klamer, Erik Pålsson, Caroline Wass, Jörgen A. Engel and Lennart Svensson and has published in prestigious journals such as Cancer, BMC Medicine and European Neuropsychopharmacology.

In The Last Decade

Birgitta Rembeck

7 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Birgitta Rembeck Sweden	5	418	132	130	128	126	8	499
Kimberly Jett Canada	10	411 1.0×	122 0.9×	156 1.2×	150 1.2×	18 0.1×	15	605
Rania Shamekh United States	12	87 0.2×	79 0.6×	21 0.2×	29 0.2×	24 0.2×	21	329
K Pulaski United States	8	395 0.9×	72 0.5×	287 2.2×	147 1.1×	5 0.0×	8	697
P Mennonna Italy	15	312 0.7×	76 0.6×	227 1.7×	116 0.9×	3 0.0×	49	582
Yoshinobu Kamio Japan	10	175 0.4×	57 0.4×	25 0.2×	56 0.4×	8 0.1×	28	326
Grace C.H. Yang United States	13	28 0.1×	97 0.7×	81 0.6×	23 0.2×	47 0.4×	18	487
Keiko Kinuya Japan	13	62 0.1×	67 0.5×	62 0.5×	15 0.1×	10 0.1×	32	387
Shin Ishihara Japan	14	57 0.1×	207 1.6×	17 0.1×	93 0.7×	14 0.1×	37	402
N. C. Notermans Netherlands	12	506 1.2×	122 0.9×	22 0.2×	77 0.6×	3 0.0×	22	644

Countries citing papers authored by Birgitta Rembeck

Since Specialization

Citations

This map shows the geographic impact of Birgitta Rembeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgitta Rembeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgitta Rembeck more than expected).

Fields of papers citing papers by Birgitta Rembeck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birgitta Rembeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgitta Rembeck. The network helps show where Birgitta Rembeck may publish in the future.

Co-authorship network of co-authors of Birgitta Rembeck

This figure shows the co-authorship network connecting the top 25 collaborators of Birgitta Rembeck. A scholar is included among the top collaborators of Birgitta Rembeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birgitta Rembeck. Birgitta Rembeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Wass, Caroline, Daniel Klamer, Erik Pålsson, et al.. (2011). L-lysine as adjunctive treatment in patients with schizophrenia: a single-blinded, randomized, cross-over pilot study. BMC Medicine. 9(1). 40–40. 18 indexed citations

2.

Schreiner, A., Dagmar Hoeben, Marjolein Lahaye, et al.. (2010). P03-126 - Patient Functioning with Flexible Doses of Paliperidone ER - a 6-month Prospective Study. European Psychiatry. 25(S1). 2 indexed citations

3.

Wass, Caroline, Daniel Klamer, Kim Fejgin, et al.. (2009). P.3.c.074 L-lysine as an add-on treatment in patients with schizophrenia. European Neuropsychopharmacology. 19. S553–S553.

4.

Zöller, Madeleine E.T., Birgitta Rembeck, & Lars Bäckman. (1997). Neuropsychological deficits in adults with Neurofibromatosis type 1. Acta Neurologica Scandinavica. 95(4). 225–232. 39 indexed citations

5.

Zöller, Madeleine E.T., et al.. (1997). Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population. Cancer. 79(11). 2125–2131. 24 indexed citations

6.

Rembeck, Birgitta, et al.. (1997). Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population. Cancer. 79(11). 2125–2131. 296 indexed citations

7.

Malmcrona, R, et al.. (1996). Heart Rhythm in Patients with Neurofibromatosis Type 1. Cardiology. 87(4). 300–302. 4 indexed citations

8.

Zöller, Madeleine E.T., Birgitta Rembeck, Hans Olof Åkesson, & Lennart Angervall. (1995). Life expectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Göteborg, Sweden.. Acta Dermato Venereologica. 75(2). 136–140. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact